Reeba K. Vikramadithyan
Bristol-Myers Squibb (India)(IN)Biocon (India)(IN)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Treatment of Major Depression, Tryptophan and brain disorders
Most-Cited Works
- → Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice(2005)172 cited
- → Inflammatory Cytokines and Fatty Acids Regulate Endothelial Cell Heparanase Expression(2004)140 cited
- → (−)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF 2725]: A Dual PPAR Agonist with Potent Antihyperglycemic and Lipid Modulating Activity(2001)136 cited
- → Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain(2016)119 cited
- → Cardiac-specific Knock-out of Lipoprotein Lipase Alters Plasma Lipoprotein Triglyceride Metabolism and Cardiac Gene Expression(2004)119 cited
- → Novel Euglycemic and Hypolipidemic Agents. 1(1998)79 cited
- → Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid‐lowering and insulin‐sensitizing efficacy in animal models(2003)79 cited
- → Antidiabetic and hypolipidemic activity of Helicteres isora in animal models(2002)76 cited
- → PAT5A: A Partial Agonist of Peroxisome Proliferator-Activated Receptor γ Is a Potent Antidiabetic Thiazolidinedione Yet Weakly Adipogenic(2003)59 cited
- → Peroxisome Proliferator-Activated Receptor Agonists Modulate Heart Function in Transgenic Mice with Lipotoxic Cardiomyopathy(2005)59 cited